Kidney regeneration and repair after transplantation

Current Opinion in Organ Transplantation

Volumn 18, Issue 2, 2013, Pages 191-196

  Franquesa, Marcella ^a   Flaquer, Maria ^b   Cruzado, Josep M ^b   Grinyó, Josep M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Hepatocyte growth factor; Kidney; Regenerative medicine; Stem cells; Transplantation

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CD133 ANTIGEN; CD24 ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 7; ENDOGLIN; INTERLEUKIN 10; SCATTER FACTOR; TRANSCRIPTION FACTOR PAX2; VASCULAR CELL ADHESION MOLECULE 1; VIMENTIN;

BIOENGINEERING; CELL POPULATION; CELL RENEWAL; ENDOTHELIAL PROGENITOR CELL; GLOMERULUS; HUMAN; KIDNEY; KIDNEY EPITHELIUM; KIDNEY PAPILLA; KIDNEY REGENERATION; KIDNEY STRUCTURE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MESENCHYMAL STEM CELL; MICROVASCULATURE; NEPHRON; NONHUMAN; PERICYTE; PROTEIN EXPRESSION; REGENERATION; REGENERATIVE MEDICINE; REVIEW; STEM CELL NICHE; STEM CELL TRANSPLANTATION;

HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 84875401743     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32835f0771     Document Type: Review

References (41)

1. Yang CW, Lee SH, Lim SW, et al. Cyclosporine or fk506 decrease mature epidermal growth factor protein expression and renal tubular regeneration in rat kidneys with ischemia/reperfusion injury. Nephron 2002;92: 914-921
2. Goncalves GM, Cenedeze MA, Feitoza CQ, et al. The role of immunosuppressive drugs in aggravating renal ischemia and reperfusion injury. Transplant Proc 2007;39: 417-420
3. Ysebaert DK, De Greef KE, Vercauteren SR, et al. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury. Kidney Int 2003;64: 864-873
4. Krankel N, Spinetti G, Amadesi S, et al. Targeting stem cell niches and trafficking for cardiovascular therapy. Pharmacol Ther 2011;129: 62-81
5. Sagrinati C, Netti GS, Mazzinghi B, et al. Isolation and characterization of multipotent progenitor cells from the bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006;17: 2443-2456
6. Ivanova L, Hiatt MJ, Yoder MC, et al. Ontogeny of CD24 in the human kidney. Kidney Int 2010;77: 1123-1131
7. Romagnani P. Toward the identification of a 'Renopoietic system'öStem Cells 2009;27: 2247-2253
8. Bussolati B, Camussi G. New insights into the renal progenitor cells and kidney diseases by studying CD133. In: Corbeil D, editor. Prominin-1 (cd133): New insights on stem & cancer cell biology. New York: Springer Science Business Media; 2013
9. Angelotti ML, Ronconi E, Ballerini L, et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 2012;30: 1714-1725
10. Bruno S, Camussi G. Isolation and characterization of resident mesenchymal stem cells in human glomeruli. Methods Mol Biol 2012;879: 367-380
11. Humphreys BD, Czerniak S, DiRocco DP, et al. Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci USA 2011;108: 9226-9231
12. Lindgren D, Bostrom AK, Nilsson K, et al. Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am J Pathol 2011;178: 828-837
13. Patschan D, Michurina T, Shi HK, et al. Normal distribution and medullary-tocortical shift of nestin-expressing cells in acute renal ischemia. Kidney Int 2007;71: 744-754
14. Oliver JA, Maarouf O, Cheema FH, et al. The renal papilla is a niche for adult kidney stem cells. J Clin Invest 2004;114: 795-804
15. Wen D, Ni L, You L, et al. Upregulation of nestin in proximal tubules may participate in cell migration during renal repair. Am J Physiol Renal Physiol 2012;303:F1534-F1544
16. Oliver JA, Maarouf O, Cheema FH, et al. SDF-1 activates papillary labelretaining cells during kidney repair from injury. Am J Physiol Renal Physiol 2012;302:F1362-F1373
17. Sullivan DC, Mirmalek-Sani SH, Deegan DB, et al. Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials 2012;33: 7756-7764
18. Ross EA, Abrahamson DR, St John P, et al. Mouse stem cells seeded into decellularized rat kidney scaffolds endothelialize and remodel basement membranes. Organogenesis 2012;8: 49-55
19. Nakayama KH, Batchelder CA, Lee CI, et al. Renal tissue engineering with decellularized rhesus monkey kidneys: Age-related differences. Tissue Eng Part A 2011;17: 2891-2901
20. Song JJ, Ott HC. Organ engineering based on decellularized matrix scaffolds. Trends Mol Med 2011;17: 424-432
21. Orlando G, Baptista P, Birchall M, et al. Regenerative medicine as applied to solid organ transplantation: Current status and future challenges. Transpl Int 2011;24: 223-232
22. Morigi M, Imberti B, Zoja C, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004;15: 1794-1804
23. Togel FE, Westenfelder C. Kidney protection and regeneration following acute injury: Progress through stem cell therapy. Am J Kidney Dis 2012;60: 1012-1022
24. Herrera MB, Bussolati B, Bruno S, et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 2007;72: 430-441
25. Eggenhofer E, Benseler V, Kroemer A, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol 2012;3: 297
26. Zonta S, De Martino M, Bedino G, et al. Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: Endovenous or arterialöTransplant Proc 2010;42: 1336-1340
27. Franquesa M, Herrero E, Torras J, et al. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev 2012;21: 3125-3135
28. Franquesa M, Hoogduijn MJ, Baan CC. The impact of mesenchymal stem cell therapy in transplant rejection and tolerance. Curr Opin Organ Transplant 2012;17: 355-361
29. Biancone L, Bruno S, Deregibus MC, et al. Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 2012;27: 3037-3042
30. Bruno S, Grange C, Deregibus MC, et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009;20: 1053-1067
31. Gatti S, Bruno S, Deregibus MC, et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusioninduced acute and chronic kidney injury. Nephrol Dial Transplant 2011;26: 1474-1483
32. Franquesa M, Alperovich G, Herrero-Fresneda I, et al. Direct electrotransfer of hHGF gene into kidney ameliorates ischemic acute renal failure. Gene Ther 2005;12: 1551-1558
33. Herrero-Fresneda I, Torras J, Franquesa M, et al. HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatoryinduced mechanisms. Kidney Int 2006;70: 265-274
34. Flaquer M, Franquesa M, Vidal A, et al. Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes. Diabetologia 2012;55: 2059- 2068
35. Jung M, Sola A, Hughes J, et al. Infusion of IL-10-expressing cells protects against renal ischemia through induction of lipocalin-2. Kidney Int 2012;81: 969-982
36. Long DA, Norman JT, Fine LG. Restoring the renal microvasculature to treat chronic kidney disease. Nat Rev Nephrol 2012;8: 244-250
37. Odorfer KI, Egerbacher M, Unger NJ, et al. Hematopoietic bone marrow cells participate in endothelial, but not epithelial or mesenchymal cell renewal in adult rats. J Cell Mol Med 2011;15: 2232-2244
38. Eirin A, Zhu XY, Krier JD, et al. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells 2012;30: 1030-1041
39. Schrimpf C, Duffield JS. Mechanisms of fibrosis: The role of the pericyte. Curr Opin Nephrol Hypertens 2011;20: 297-305
40. Lin SL, Chang FC, Schrimpf C, et al. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am J Pathol 2011;178: 911-923
41. Smith SW, Schrimpf C, Parekh DJ, et al. A novel therapeutic target in interstitial fibrosis. Histol Histopathol 2012;27: 1503-1514